Association of complementing circulating tumor DNA and circulating tumor cells load on stable and progressive disease in treated patients. Development, comparative study, and external validation of a ...

Performing large scale plasma profiling studies involving thousands of samples are challenging due to both lengthy sample preparation and long instrument time requirements. We present a fully ...

Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer Chemotherapy-induced peripheral neuropathy (CIPN) is a ...

Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the ...

Cancer is a highly heterogeneous disease in need of accurate and non-invasive diagnostic tools. Here, we describe a novel strategy to explore the proteome signature by comprehensive analysis of ...

In a recent study published in Nature Microbiology, researchers developed integrated host-microbe plasma metagenomics to facilitate sepsis diagnosis. Study: Integrated host-microbe plasma metagenomics ...

Studies spanning cardiovascular, aging, and cancer biology highlight how Seer’s Proteograph® platform is enabling discovery at population scale ...

ZURICH--(BUSINESS WIRE)--Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced they will be presenting major scientific and technological ...

Type 2 diabetes is a challenge in modern healthcare, and animal models are necessary to identify underlying mechanisms. The Nile rat (Arvicanthis niloticus) develops diet-induced diabetes rapidly on a ...

Researchers have developed an enhanced LC-MS/MS method capable of quantifying 18 steroids—including key corticosteroid and sex steroid hormones, as well as intermediates involved in corticosteroid ...